Abstract:Background and Aims: Cancer cells prefer aerobic glycolysis to maintain growth advantages, but the role of long non-coding RNAs (lncRNAs) in glycometabolism still remains unclear. Here we identified one cytoplasmic lncRNA LINC01554 as a significantly downregulated lncRNA in hepatocellular carcinoma (HCC) and aimed to investigate its role in cellular glucose metabolism in the development and progression of HCC. Methods: Quantitative real-time PCR was used to determine the expression level of LINC01554. Downregulation of LINC01554 by miR-365a at transcriptional level was assessed by luciferase reporter assay. Subcellular fractionation assay and RNA fluorescence in situ hybridization were performed to detect the subcellular localization of LINC01554. RNA pull-down assay, mass spectrometry, and RNA immunoprecipitation assay were used to identify the underlying molecular mechanisms. The tumor-suppressive function of LINC01554 was determined by both in vitro assay and nude mice xenograft model. Results: LINC01554 was frequently downregulated in HCC, which was significantly associated with tumor invasion (P = 0.005), tumor size (P = 0.041), tumor staging (P = 0.023) and shorter survival (P = 0.035) of HCC patients. Luciferase reporter assay unraveled that LINC01554 was negatively regulated by miR-365a. Subcellular fractionation assay and RNA FISH revealed the cytoplasmic predominance of LINC01554 in MIHA cells and HCC clinical samples. Ectopic expression of LINC01554 inhibited HCC cell growth, colony formation in soft agar, foci formation, and tumor formation in nude mice. LINC01554 promoted the ubiquitin-mediated degradation of PKM2 and inhibited Akt/mTOR signaling pathway to abolish aerobic glycolysis in HCC cells. Further study found that LINC01554-knockout could effectively reverse the tumor-suppressive effect of LINC01554. Conclusions: Our results identify LINC01554 as a novel tumor suppressor in HCC and unravel its underlying molecular mechanism in reprogramming cellular glucose metabolism. LINC01554 could possibly serve as a novel prognostic biomarker and provide the rationale for HCC therapy.

ANGPTL1 Interacts with Integrin Α1β1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.

LncRNA AY promotes hepatocellular carcinoma metastasis by stimulating ITGAV transcription.

ANGPTL1 Attenuates Colorectal Cancer Metastasis by Up-Regulating Microrna-138

Downregulation of AZGP1 by Ikaros and Histone Deacetylase Promotes Tumor Progression Through the PTEN/Akt and CD44s Pathways in Hepatocellular Carcinoma.

ANGPTL1, Foxo3a-Sox2, and Colorectal Cancer Metastasis

Hypoxia-inducible Factor 1 Alpha-Activated Angiopoietin-Like Protein 4 Contributes to Tumor Metastasis Via Vascular Cell Adhesion Molecule-1/Integrin Β1 Signaling in Human Hepatocellular Carcinoma.

Effect of Deletion of ANGPTL4 Gene on Viability, Migration and Invasion Ability and Apoptosis of Hepatocellular Carcinoma Cells

Therapeutic Inhibition of Phospholipase D1 Suppresses Hepatocellular Carcinoma.

Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating Kupffer cell secretion pattern and impeding MMP9 induced vascular leakiness

Tumor Suppressor CLCA1 Inhibits Angiogenesis Via TGFB1/SMAD/VEGF Cascade and Sensitizes Hepatocellular Carcinoma Cells to Sorafenib.

Effects of ANGPTL3 Antisense Oligodeoxynucleotides Transfection on the Cell Growths and Invasion of Human Hepatocellular Carcinoma Cells.

Alpha1-ACT Functions As a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway Via Activation of PTEN

Downregulation Of Notch1 Inhibits The Invasion Of Human Hepatocellular Carcinoma Hepg2 And Mhcc97h Cells Through The Regulation Of Pten And Fak

ATE1 Inhibits Liver Cancer Progression through RGS5-Mediated Suppression of Wnt/-Catenin Signaling

Exosomal miR-3682-3p Suppresses Angiogenesis by Targeting ANGPT1 via the RAS-MEK1/2-ERK1/2 Pathway in Hepatocellular Carcinoma

Downregulation of Fgl2/Prothrombinase Delays Hcclm6 Xenograft Tumour Growth and Decreases Tumour Angiogenesis

ANGPTL4 Overexpression Inhibits Tumor Cell Adhesion and Migration and Predicts Favorable Prognosis of Triple-Negative Breast Cancer

Angiopoietin-Related Protein 4-Transcript 3 Increases the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma Cells and Inhibits Apoptosis

LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway

FGL2/PROTHROMBINASE CONTRIBUTES TO HCC TUMOR GROWTH AND ANGIOGENESIS THROUGH THE MAPK PATHWAY

The Downregulation of ANGPTL4 Inhibits the Migration and Proliferation of Tongue Squamous Cell Carcinoma.